← FDA Drug Approvals (Drugs@FDA)

BYSANTI

NDA · New Drug Application · Sponsor: VANDA PHARMS INC · Approved 2026-02-20

Drug application

FDA Application #

NDA220358

Application type

New Drug Application

Brand name

BYSANTI

Generic name

Milsaperidone

Active ingredients

MILSAPERIDONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

VANDA PHARMS INC

First approval

2026-02-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown